Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Laura Muiños"'
Autor:
Ana Vivancos, Martin Schlumberger, Marcia S. Brose, Josep Tabernero, Carol E. Peña, Guillermo Villacampa, Jorge Hernando, Laura Muiños, Zighereda Ogbah, Hector G. Palmer, Carles Zafon, Paolo Nuciforo, Carmela Iglesias, Francesco M. Mancuso, Ignacio Matos, Jaume Capdevila
Table 1: samples included in the RNAseq analysis Figure 1: consort flow diagram Table 2: Comparison of patients' characteristics of the subset of patients included in the RNA-seq analysis and patients recruited in the DECISION study Figure 2: Progres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c10c90a69713d1f9b51f661f310fa0f9
https://doi.org/10.1158/1535-7163.22506703
https://doi.org/10.1158/1535-7163.22506703
Autor:
Ana Vivancos, Martin Schlumberger, Marcia S. Brose, Josep Tabernero, Carol E. Peña, Guillermo Villacampa, Jorge Hernando, Laura Muiños, Zighereda Ogbah, Hector G. Palmer, Carles Zafon, Paolo Nuciforo, Carmela Iglesias, Francesco M. Mancuso, Ignacio Matos, Jaume Capdevila
Several biomarkers have been suggested to have prognostic value in differentiated thyroid carcinomas (DTC) with no validation in the refractory setting, including all tumor subtypes. We aim to correlate RNA expression profiles with survival based on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::861f9df5fe8dd4801e1ea9c551c3a4bc
https://doi.org/10.1158/1535-7163.c.6538471.v1
https://doi.org/10.1158/1535-7163.c.6538471.v1
Autor:
Martin Schlumberger, Marcia S. Brose, Laura Muiños, Carmela Iglesias, Jorge Hernando, Josep Tabernero, Hector G. Palmer, Zighereda Ogbah, Ignacio Matos, Ana Vivancos, Jaume Capdevila, Carles Zafon, Carol Peña, Guillermo Villacampa, Francesco M. Mancuso, Paolo Nuciforo
Publikováno v:
Molecular Cancer Therapeutics. 19:312-317
Several biomarkers have been suggested to have prognostic value in differentiated thyroid carcinomas (DTC) with no validation in the refractory setting, including all tumor subtypes. We aim to correlate RNA expression profiles with survival based on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fcf2a07dd0018478a6d104b1390be8f
https://doi.org/10.1158/1535-7163.mct-19-0211
https://doi.org/10.1158/1535-7163.mct-19-0211
Autor:
Zighereda Ogbah, Hector G. Palmer, Carmela Iglesias, Paolo Nuciforo, Martin Schlumberger, Carol Peña, Jaume Capdevila, Marcia S. Brose, Laura Muiños, Ana Vivancos, Carles Zafon, Ignacio Matos Garcia, Francesco M. Mancuso
Publikováno v:
Journal of Clinical Oncology. 35:6083-6083
6083 Background: In DECISION, sorafenib significantly impacted progression-free survival (PFS) and response rate (RR) in radioactive-iodine refractory DTC. The aim of this biomarker study was to identify RNA expression profiles related with PFS, over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bccc56bcece8a267252bd90cc22eb3a
https://doi.org/10.1200/jco.2017.35.15_suppl.6083
https://doi.org/10.1200/jco.2017.35.15_suppl.6083
Autor:
María Isabel Pérez Moreiras, Laura Muiños Ruano, José Félix Arija Val, Lucía Dorado Castro, Leticia Alonso Fernández, Rocío González López
Publikováno v:
RUNA. Repositorio da Consellería de Sanidade e Sergas
Servizo Galego de Saúde (SERGAS)
Servizo Galego de Saúde (SERGAS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f182b864ed2369d7b95717aa8ee3dc5
https://doi.org/10.1016/j.gastrohep.2011.11.012
https://doi.org/10.1016/j.gastrohep.2011.11.012